Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. How Much Does Link.springer.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00210-025-03791-y.

Title:
Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy | Naunyn-Schmiedeberg's Archives of Pharmacology
Description:
One of the most common tumors is hepatocellular carcinoma (HCC), and the prognosis for late-stage HCC is still not good. It is anticipated that improved outcomes would result from a deeper comprehension of the pathophysiology of HCC. Ferroptosis as a new discovered cell death type is linked to the progression of HCC and may be crucial for its detection, prevention, therapy, and prognosis. Numerous studies suggest that epigenetic alterations mediated by non-coding RNAs (ncRNA) might influence cancer cell susceptibility to ferroptosis. This study elucidates the processes of ferroptosis and delineates the paths by which ncRNAs influence HCC by modulating ferroptosis. Furthermore, it offers significant insights into ferroptosis-associated ncRNAs, intending to discover novel therapeutic approaches for HCC. It also explores innovative concepts for the future use of ncRNA-based ferroptosis-targeted therapeutics.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?


Link.springer.com relies on WOOCOMMERCE.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}


E-COMMERCE {🛒}


Link.springer.com is an e-commerce website built with woocommerce. Below, we provide further estimates of its revenues.

How Much Does Link.springer.com Make? {💰}

Keywords {🔍}

pubmed, google, scholar, cas, ferroptosis, central, carcinoma, cancer, hepatocellular, wang, cell, zhang, liu, liver, death, chen, cells, noncoding, rna, role, rnas, mol, article, therapy, front, biol, hcc, int, huang, targeting, tumor, protein, sci, tang, zhou, med, long, factor, treatment, pharmacol, res, oncol, axis, therapeutic, sun, resistance, sorafenib, jiang, patients, promotes,

Topics {✒️}

lncrna h19/mir-19b-3p/fth1 axis targeting lncrna pvt1/mir-214–3p/gpx4 mir-455-3p/nupr1/fth1 axis hsa-mir-199a-5p panel p62-keap1-nrf2 pathway protects puerarin-loaded peg-pe micelles targeting mir-382-5p/slc7a11 axis glutamate-cysteine ligase inhibitors nrf1/ran/dld protein complex single-cell rna sequencing mir-541-3p/gpx4 axis month download article/chapter ncrna-based ferroptosis-targeted therapeutics mir-362-3p/miox axis mir-3200-5p/atf4 axis circ0097009/mir-1261/slc7a11 axis adsorbing mir-450b-5p exosomal mir-142-3p secreted multi-omic analysis reveals ferroptosis-related gene signature mir-654-5p promote ferroptosis suppresses sorafenib-induced ferroptosis mir-21-5p inhibits ferroptosis jak1/stat3 signaling pathway enhanced anti-apoptotic effect enhances anti-pd1 immunotherapy small-cell lung cancer microrna-670-3p suppresses ferroptosis el-aziz mka cancer-related immune functions akt/mtor signaling pathway egyptian fibrotic/cirrhotic patients promising diagnostic/prognostic biomarker dendritic-cell-targeting virus virus–related hepatocellular carcinoma nrf2/ho-1 axis mir-590-3p sponge hsa-mir-21–5p hsa-mir-192–5p hsa-mir-155–5p tfr1-dependent manner el mesallamy ho oncogenic kras protein privacy choices/manage cookies rna interference promotes iron-dependent form lncrna gabpb1-as1 avert sorafenib resistance alleviate sorafenib resistance silencing op18/stathmin

Questions {❓}

  • Bhangui P (2024) Liver transplantation and resection in patients with hepatocellular cancer and portal vein tumor thrombosis: Feasible and effective?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
         description:One of the most common tumors is hepatocellular carcinoma (HCC), and the prognosis for late-stage HCC is still not good. It is anticipated that improved outcomes would result from a deeper comprehension of the pathophysiology of HCC. Ferroptosis as a new discovered cell death type is linked to the progression of HCC and may be crucial for its detection, prevention, therapy, and prognosis. Numerous studies suggest that epigenetic alterations mediated by non-coding RNAs (ncRNA) might influence cancer cell susceptibility to ferroptosis. This study elucidates the processes of ferroptosis and delineates the paths by which ncRNAs influence HCC by modulating ferroptosis. Furthermore, it offers significant insights into ferroptosis-associated ncRNAs, intending to discover novel therapeutic approaches for HCC. It also explores innovative concepts for the future use of ncRNA-based ferroptosis-targeted therapeutics.
         datePublished:2025-01-16T00:00:00Z
         dateModified:2025-01-16T00:00:00Z
         pageStart:6335
         pageEnd:6348
         sameAs:https://doi.org/10.1007/s00210-025-03791-y
         keywords:
            Liver cancer
            Epigenetic
            Hepatocellular cancer
            Ferroptosis
            NcRNA
            Pharmacology/Toxicology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-03791-y/MediaObjects/210_2025_3791_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-03791-y/MediaObjects/210_2025_3791_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-03791-y/MediaObjects/210_2025_3791_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-03791-y/MediaObjects/210_2025_3791_Fig4_HTML.jpg
         isPartOf:
            name:Naunyn-Schmiedeberg's Archives of Pharmacology
            issn:
               1432-1912
               0028-1298
            volumeNumber:398
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Weijia Wang
               affiliation:
                     name:Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital)
                     address:
                        name:Department of Oncology, Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital), Shandong Province, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Behishta Hashimi
               affiliation:
                     name:Jahan Institute of Health Sciences
                     address:
                        name:Department of Midwifery, Jahan Institute of Health Sciences, Kabul, Afghanistan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ping Wang
               url:http://orcid.org/0009-0008-6761-0379
               affiliation:
                     name:Yantaishan Hospital Affiliated to Binzhou Medical University
                     address:
                        name:Department of Oncology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
      description:One of the most common tumors is hepatocellular carcinoma (HCC), and the prognosis for late-stage HCC is still not good. It is anticipated that improved outcomes would result from a deeper comprehension of the pathophysiology of HCC. Ferroptosis as a new discovered cell death type is linked to the progression of HCC and may be crucial for its detection, prevention, therapy, and prognosis. Numerous studies suggest that epigenetic alterations mediated by non-coding RNAs (ncRNA) might influence cancer cell susceptibility to ferroptosis. This study elucidates the processes of ferroptosis and delineates the paths by which ncRNAs influence HCC by modulating ferroptosis. Furthermore, it offers significant insights into ferroptosis-associated ncRNAs, intending to discover novel therapeutic approaches for HCC. It also explores innovative concepts for the future use of ncRNA-based ferroptosis-targeted therapeutics.
      datePublished:2025-01-16T00:00:00Z
      dateModified:2025-01-16T00:00:00Z
      pageStart:6335
      pageEnd:6348
      sameAs:https://doi.org/10.1007/s00210-025-03791-y
      keywords:
         Liver cancer
         Epigenetic
         Hepatocellular cancer
         Ferroptosis
         NcRNA
         Pharmacology/Toxicology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-03791-y/MediaObjects/210_2025_3791_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-03791-y/MediaObjects/210_2025_3791_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-03791-y/MediaObjects/210_2025_3791_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00210-025-03791-y/MediaObjects/210_2025_3791_Fig4_HTML.jpg
      isPartOf:
         name:Naunyn-Schmiedeberg's Archives of Pharmacology
         issn:
            1432-1912
            0028-1298
         volumeNumber:398
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Weijia Wang
            affiliation:
                  name:Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital)
                  address:
                     name:Department of Oncology, Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital), Shandong Province, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Behishta Hashimi
            affiliation:
                  name:Jahan Institute of Health Sciences
                  address:
                     name:Department of Midwifery, Jahan Institute of Health Sciences, Kabul, Afghanistan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ping Wang
            url:http://orcid.org/0009-0008-6761-0379
            affiliation:
                  name:Yantaishan Hospital Affiliated to Binzhou Medical University
                  address:
                     name:Department of Oncology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Naunyn-Schmiedeberg's Archives of Pharmacology
      issn:
         1432-1912
         0028-1298
      volumeNumber:398
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital)
      address:
         name:Department of Oncology, Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital), Shandong Province, China
         type:PostalAddress
      name:Jahan Institute of Health Sciences
      address:
         name:Department of Midwifery, Jahan Institute of Health Sciences, Kabul, Afghanistan
         type:PostalAddress
      name:Yantaishan Hospital Affiliated to Binzhou Medical University
      address:
         name:Department of Oncology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Weijia Wang
      affiliation:
            name:Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital)
            address:
               name:Department of Oncology, Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital), Shandong Province, China
               type:PostalAddress
            type:Organization
      name:Behishta Hashimi
      affiliation:
            name:Jahan Institute of Health Sciences
            address:
               name:Department of Midwifery, Jahan Institute of Health Sciences, Kabul, Afghanistan
               type:PostalAddress
            type:Organization
      name:Ping Wang
      url:http://orcid.org/0009-0008-6761-0379
      affiliation:
            name:Yantaishan Hospital Affiliated to Binzhou Medical University
            address:
               name:Department of Oncology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Oncology, Qilu Hospital of Shandong University Dezhou Hospital (Dezhou People’s Hospital), Shandong Province, China
      name:Department of Midwifery, Jahan Institute of Health Sciences, Kabul, Afghanistan
      name:Department of Oncology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(350)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.16s.